Antiplatelet properties of natural products

Gemma Vilahur1, Lina Badimon

  • 1Centro de Investigación Cardiovascular, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau and IIB-Santpau, Spain.

Vascular Pharmacology
|September 3, 2013
PubMed

Insights

Natural foods and their compounds, like those in the Mediterranean diet, show promise in preventing cardiovascular diseases by reducing blood clot formation. These dietary components offer cardioprotective effects and antiplatelet activities.

Area of Science:

  • Cardiovascular Medicine and Nutrition Science
  • Focuses on the intersection of diet, atherothrombosis, and cardiovascular health.

Background:

  • Cardiovascular diseases (CVD), driven by atherothrombosis, are leading causes of global mortality.
  • Existing treatments include managing risk factors and antithrombotic agents.
  • Growing interest in natural food products and bioactive compounds for cardiovascular disorder prevention and treatment.

Purpose of the Study:

  • To review the antiplatelet properties of natural products and food-derived bioactive constituents.
  • To explore the mechanisms underlying these antiplatelet activities in the context of atherothrombosis.

Main Methods:

  • Literature review of the atherothrombotic process.
  • Up-to-date review of antiplatelet properties of specific natural products and food constituents.
  • Discussion of underlying antiplatelet mechanisms.

Main Results:

  • Healthy diets, such as the Mediterranean diet, offer cardioprotective effects in CVD prevention.
  • Beneficial effects are linked to improved lipid profiles, vascular function, and reduced oxidative stress and inflammation.
  • Natural dietary compounds, including ω-3 PUFA, olive oil, garlic, onions, tomatoes, mushrooms, polyphenol-rich beverages, and cocoa, exhibit antiplatelet activities.

Conclusions:

  • Natural food products and their bioactive components play a role in preventing and treating cardiovascular disorders.
  • Dietary interventions, particularly those rich in functional foods, can modulate key pathways in atherosclerosis.
  • The antiplatelet effects of these natural compounds contribute to reducing thrombotic risk in cardiovascular disease.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...